1. Effects of CLDN9 on Proliferation of Uterine Corpus Endometrioid Carcinoma Cells
   Jiayu Zhang et al, 2023, Proceedings of the 2023 15th International Conference on Bioinformatics and Biomedical Technology CrossRef
2. Antibody-mediated targeting of Claudins in cancer
   Benjamin Vonniessen et al, 2024, Frontiers in Oncology CrossRef
3. Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance
   Xinguo Zhuang et al, 2023, Biomedicines CrossRef
4. Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity
   Xingbin Hu et al, 2024, Cancer Pathogenesis and Therapy CrossRef
5. The Expression of the Claudin Family of Proteins in Colorectal Cancer
   Kristin E. Cox et al, 2024, Biomolecules CrossRef
6. Finding the junction between claudins and endometrial carcinoma
   Davide Capoferri et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. Action of m6A-related gene signatures on the prognosis and immune microenvironment of colonic adenocarcinoma
   Han Shugao et al, 2024, Heliyon CrossRef
8. Claudins in Cancer: A Current and Future Therapeutic Target
   Caroline Hana et al, 2024, International Journal of Molecular Sciences CrossRef
9. Identification of Biomarkers and Prognostic Analysis for Endometrial Cancer Patients Based on the ERBB Family
   Long-Xing Wang et al, 2024, Proceedings of the 2024 16th International Conference on Bioinformatics and Biomedical Technology CrossRef